JPRN-UMIN000001626
Completed
Phase 2
eoadjuvant chemoradiotherapy followed by esophagectomy for REG I positive T4, N4 or many thoracic esophageal cancer - Neoadjuvant chemoradiotherapy followed by esophagectomy for REG I positive T4, N4 or many thoracic esophageal cancer
The Cancer Board of Esophageal Cancer in Akita University Hospital0 sites30 target enrollmentJanuary 7, 2009
Conditionsthoracic esophageal cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- thoracic esophageal cancer
- Sponsor
- The Cancer Board of Esophageal Cancer in Akita University Hospital
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) treatment history of chemotherapy or radiotherapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Eoadjuvant chemoradiotherapy for Esophageal squamous cell carcinoma versus Definitive chemoradiotherapy with salvage Surgery as needed (The NEEDS Trial)Resectable locally advanced squamous cell carcinoma (SCC) of the esophagusTherapeutic area: Diseases [C] - Neoplasms [C04]CTIS2022-500966-82-00Karolinska University Hospital1,010
Active, not recruiting
Phase 1
Combined chemotherapy and radiotherapy followed by planned surgery compared to combined chemotherapy and radiotherapy with surgery only when really needed, for patients with cancer in the esophagus.Resectable locally advanced squamous cell carcinoma (SCC) of the esophagusMedDRA version: 21.1Level: LLTClassification code 10025899Term: Malignant neoplasm of esophagusSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10025901Term: Malignant neoplasm of esophagus, unspecifiedSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2020-000149-15-IEKarolinska University Hospital1,020
Active, not recruiting
Phase 1
Combined chemotherapy and radiotherapy followed by planned surgery compared to combined chemotherapy and radiotherapy with surgery only when really needed, for patients with cancer in the esophagus.Resectable locally advanced squamous cell carcinoma (SCC) of the esophagusMedDRA version: 21.1Level: LLTClassification code 10025899Term: Malignant neoplasm of esophagusSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10025901Term: Malignant neoplasm of esophagus, unspecifiedSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2020-000149-15-SEKarolinska University Hospital1,020
Active, not recruiting
Phase 1
Combined chemotherapy and radiotherapy followed by planned surgery compared to combined chemotherapy and radiotherapy with surgery only when really needed, for patients with cancer in the esophagus.Resectable locally advanced squamous cell carcinoma (SCC) of the esophagusMedDRA version: 21.1Level: LLTClassification code 10025899Term: Malignant neoplasm of esophagusSystem Organ Class: 100000004864MedDRA version: 21.1Level: LLTClassification code 10025901Term: Malignant neoplasm of esophagus, unspecifiedSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2020-000149-15-NOKarolinska University Hospital1,020
Not yet recruiting
Phase 2
EO-ADJUVANT RADIOTHERAPY-CHEMOTHERAPY IN STOMACH CANCER Induction therapy with carboplatin, paclitaxel and radiotherapy in patients with locally advanced gastric cancergastric cancerstomach cancer1001799010017991NL-OMON31088Antoni van Leeuwenhoek Ziekenhuis53